Artificial Intelligence in Medicine: What are the challenges and opportunities?


Session Description: Artificial intelligence (AI) is poised to disrupt and revolutionize medical fields via data-driven solutions to improve patient outcome. In this session, we’ll discuss how AI-based techniques impact and improve health care for single ventricle disease patients with opportunities including disease diagnosis using AI in cardiac imaging, AI-based electrogram analysis and monitoring, benefits of AI in digital pathology in histopathological analyses, AI in early symptom prediction and identification of high-risk patients, AI in clinical workflow augmentation and hospital optimization, and AI in drug and gene treatment development. We’ll also discuss how AI tools have the potential to suffer from a host of shortcomings, including an inapplicability outside of the training domain and bias and a complex evolving relationship between clinicians and AI tools.


Markus Rottmann, PhD, Northwestern University


Collin Stultz, MD, PhD, Massachusetts General Hospital, MIT

Jagmeet Singh, MD, PhD, Massachusetts General Hospital, Harvard University


Related Articles